Increase in Respiratory Diseases and Disorders to Foster the Growth of the Global Respiratory Drugs and Devices Market

Published: Dec 2019

The global respiratory drugs and devices market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2021-2027). An increase in respiratory diseases and disorders is expected to drive the demand of the market for respiratory drugs and devices. Due to this rapid increase in the demand for protective equipment that includes masks along with ventilators had been observed. These have resulted in increasing manufacturing speed related to respiratory equipment in health care industries. Further, beneficiary policies by governments are also encouraging manufacturing along with the sales of respiratory devices which is also supporting the growth of the market.

Browse the full report description of "Global Respiratory Drugs and Devices Market Research By Product (Respiratory Therapeutic Devices, Respiratory Diagnostic and Monitoring Devices, and Respiratory Consumables and Accessories Meters), By Respiratory Drugs (Respiratory Drugs by Route of Administration and Respiratory Drugs by Drug Class), and By End-Users (Hospitals, Home Care and Other End-Users) Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/respiratory-drugs-devices-market

The key players present in the global respiratory drugs and devices market had been adopting various strategies that include mergers and acquisitions and collaboration to gain major market share. For instance, in September 2021, AstraZeneca, and Amgen along with various other leading respiratory clinicians had brought out the International Respiratory Coalition, which is regarded as a new partnership to transform post-pandemic respiratory healthcare. Additionally, this partnership will support governments and healthcare systems in recovering from COVID-19 by strengthening respiratory care.

Market Coverage

    • The market number available for – 2021-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Product

o By Respiratory Drugs

o By End-Users

    • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape - AstraZeneca, Bayer AG, Ge Healthcare Ltd., GlaxoSmithKline, and Novartis AG

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Respiratory Drugs and Devices Market 

By Product 

    • Respiratory Therapeutic Devices

    • Respiratory Diagnostic and Monitoring Devices 

    • Respiratory Consumables and Accessories Meters

By Respiratory Drugs 

    • Respiratory Drugs By Route Of Administration

    • Respiratory Drugs By Drug Class

By End-User 

    • Hospitals

    • Home Care

    • Other End-Users 

Global Respiratory Drugs and Devices Market by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/respiratory-drugs-devices-market